Abstract
Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p
| Original language | English (US) |
|---|---|
| Pages (from-to) | 803-811 |
| Number of pages | 9 |
| Journal | Substance Use and Misuse |
| Volume | 51 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jun 6 2016 |
Fingerprint
Keywords
- buprenorphine
- Crime
- methadone
- opioid agonist treatment
- opioid-related disorders
ASJC Scopus subject areas
- Psychiatry and Mental health
- Public Health, Environmental and Occupational Health
- Health(social science)
- Medicine (miscellaneous)
Cite this
Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment : A Comparison of Methadone Maintenance and Office-based Buprenorphine. / Rastegar, Darius A.; Sharfstein Kawasaki, Sarah; King, Van L.; Harris, Elizabeth E.; Brooner, Robert K.
In: Substance Use and Misuse, Vol. 51, No. 7, 06.06.2016, p. 803-811.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment
T2 - A Comparison of Methadone Maintenance and Office-based Buprenorphine
AU - Rastegar, Darius A.
AU - Sharfstein Kawasaki, Sarah
AU - King, Van L.
AU - Harris, Elizabeth E.
AU - Brooner, Robert K.
PY - 2016/6/6
Y1 - 2016/6/6
N2 - Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p
AB - Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p
KW - buprenorphine
KW - Crime
KW - methadone
KW - opioid agonist treatment
KW - opioid-related disorders
UR - http://www.scopus.com/inward/record.url?scp=84964528875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964528875&partnerID=8YFLogxK
U2 - 10.3109/10826084.2016.1155608
DO - 10.3109/10826084.2016.1155608
M3 - Article
VL - 51
SP - 803
EP - 811
JO - Substance Use and Misuse
JF - Substance Use and Misuse
SN - 1082-6084
IS - 7
ER -